Mindfulness-Based Cognitive Therapy for Preventing Depression Relapse

Mindfulness-based cognitive therapy (MBCT) is an 8-week group program designed to prevent depression from coming back in people who have recovered from repeated episodes. It combines mindfulness practice with elements of cognitive therapy, teaching you to notice early shifts in mood and thinking and to respond to them differently before they build into a full relapse.

The evidence is solid for this specific use. A 2016 individual-patient-data meta-analysis of 1,258 people found that MBCT reduced the risk of relapse over about 60 weeks compared with not receiving it. In the PREVENT trial, MBCT with support to taper antidepressants did about as well as staying on maintenance antidepressants, but did not outperform them. That is an option to discuss with your prescriber, never a reason to stop medication on your own.

What MBCT is designed to do

MBCT was built as a relapse-prevention treatment. The original trial described it as a group intervention to train recovered, recurrently depressed patients to disengage from the depressive thinking that low mood can switch on, which may drive relapse. The idea is that after several episodes, a small dip in mood can more easily trigger old patterns of rumination and self-criticism. MBCT does not try to argue with those thoughts. It teaches you to recognize them as passing mental events and to step out of autopilot.

NICE, the UK guideline body, summarizes mindfulness-based group programs as focusing on the present, observing and sitting with thoughts, feelings and bodily sensations, and on increasing awareness of thoughts and feelings rather than changing them. It also notes that these programs do not directly help with relationship, employment or other stressors that may be contributing.

How the 8-week group works

Most MBCT courses follow a similar structure. In the PREVENT trial, the program was eight group sessions of 2.25 hours, normally on consecutive weeks, with four refresher sessions offered roughly every 3 months over the following year. NICE describes relapse-prevention courses of group CBT or MBCT as usually 8 sessions over 2 to 3 months, with the option of additional sessions over the next 12 months.

Participants learn mindfulness practices and cognitive-behavioral skills both in session and through homework, with the aim of becoming more aware of the bodily sensations, thoughts and feelings linked to relapse and relating to them constructively. NICE describes mindfulness groups as including breathing exercises. Courses then turn these skills toward relapse prevention. NICE says relapse-prevention components may include reviewing what helped, making concrete plans to keep progress going, identifying triggers and warning signs with contingency plans, and planning for anticipated challenges over the next year.

The home practice is substantial, and NICE notes that people need to be willing to complete it. Many participants find the time commitment the hardest part. It helps to look at your schedule honestly before starting.

Who MBCT is for

MBCT has the strongest evidence for people who are currently well, or mostly well, after several episodes of depression.

• Number of past episodes. In the original 2000 trial of 145 recovered patients, MBCT reduced relapse risk for people with three or more previous episodes, who made up 77% of the sample, but not for those with only two. PREVENT also enrolled people with three or more previous episodes.
• Remaining symptoms. The 2016 meta-analysis found some evidence that people with more severe depressive symptoms before treatment benefited more from MBCT than from comparison treatments. The authors concluded it was particularly useful for those with more pronounced residual symptoms.
• Recovery status. The trials in the meta-analysis enrolled people with recurrent depression in full or partial remission.

MBCT is less suitable as a first treatment in the middle of a severe episode, when concentration and energy for a group and daily practice are limited. NICE does list group mindfulness programs among the options for a new episode of less severe depression. If you are currently very unwell, the more urgent decision is how to treat the episode itself; see depression treatment options compared.

What the evidence shows

Three studies anchor the evidence. The table summarizes them.

A hazard ratio of 0.69 means that, at any point during follow-up, people who received MBCT were about 31% less likely to relapse than those who did not, on average. That is a meaningful reduction, not elimination of risk. In PREVENT, nearly half of both groups still relapsed within two years, which is a reminder that recurrent depression is a long-term condition in both treatment arms.

Two caveats are worth stating plainly. Most authors of the 2016 meta-analysis were investigators on the original trials, and several receive royalties or training fees related to MBCT, which they disclosed. And the advantage over other active treatments (hazard ratio 0.79) was smaller than the advantage over not receiving MBCT, so the edge over other good treatments is modest.

MBCT or maintenance antidepressants?

This is the question many people bring to MBCT. PREVENT tested it directly. Participants were on a therapeutic dose of maintenance antidepressants and were randomized either to continue them or to take MBCT with support to taper or stop. Tapering was planned with the participant's own doctor, who was prompted to discuss a tapering or discontinuation regimen partway through the course.

The result was a draw. Time to relapse did not differ over 24 months, and the authors found no evidence that MBCT was superior to staying on medication. Both groups had enduring positive outcomes on relapse, residual symptoms and quality of life.

NICE's 2022 guideline reflects this. For people who recovered on an antidepressant but are at higher risk of relapse, it suggests considering continuing the antidepressant, or a course of group CBT or MBCT for people who do not wish to continue on antidepressants, or both together. It also asks clinicians to discuss the potential risks of long-term antidepressant use, such as side effects and difficulty stopping, against the risk of relapse.

Stopping an antidepressant can cause discontinuation symptoms, and depression can return. Any taper should be planned and paced by your prescriber. The guides to switching antidepressants and ongoing medication management explain how those decisions are usually handled. If you are thinking about suicide or are in crisis, call or text 988 (the 988 Suicide & Crisis Lifeline) or go to the nearest emergency room.

MBCT compared with other mindfulness and therapy options

• General mindfulness apps and classes. These can be pleasant and useful for stress, but they are not the same as MBCT, which is a specific program built around depression relapse. The evidence above applies to manualized MBCT, not to mindfulness in general.
• Group CBT for relapse prevention. NICE places it alongside MBCT as a relapse-prevention option. CBT works more directly on changing thoughts, while MBCT emphasizes awareness rather than change.
• Continuing individual therapy. If you recovered with a therapy such as CBT or interpersonal therapy, continuing that therapy is another route NICE describes for people at higher risk.
• Acceptance and commitment therapy shares MBCT's interest in mindfulness but is a different therapy with its own evidence.

If the group format worries you, the guide to group vs individual therapy covers privacy, fit and what group sessions are like. The practice's article on mindfulness in mental health treatment offers broader background.

An example relapse-prevention plan

Writing down your own plan is one way to put this into practice. NICE suggests that relapse-prevention work identify stressful circumstances, triggering events, warning signs such as anxiety or poor sleep, and unhelpful behaviors such as avoidance or rumination that have come before past episodes, with a detailed plan for each. The table below shows the kind of structure a plan might take. It is an illustration, not a template to follow without your clinician.

The value of a written plan is that it is made while you are well. When mood drops, it is hard to think clearly about what helps, and a plan made in advance does some of that thinking for you.

Making the home practice workable

The daily practice is where many people struggle, and it is worth planning for before the course starts.

• Pick a fixed time. Attaching practice to an existing routine, such as after morning coffee, makes it easier to keep.
• Expect a wandering mind. Noticing that your attention has drifted and bringing it back is the practice, not a failure of it.
• Talk about obstacles in the group. Teachers expect missed practices and use them as material for discussion.
• Keep the shorter practices after the course ends. Brief daily practices are easier to sustain than long ones, and the refresher sessions some programs offer can help you restart.

Is MBCT safe?

In PREVENT, the number of serious adverse events did not differ between groups, and none were attributed to the interventions. That said, NICE notes that group mindfulness may be difficult for people experiencing intense or highly distressing thoughts, or who find focusing on the body difficult. Ask the teacher before you join whether there is a pre-course meeting to talk this through. If you are currently in a severe episode, have active suicidal thoughts, or are dealing with psychosis or an unstable bipolar disorder, speak with a psychiatrist before starting.

Questions to ask before you enroll

• Is this a manualized MBCT course designed for recurrent depression, or a general mindfulness class?
• What training do the teachers have, and will there be two facilitators?
• How many people are in the group, and is there an individual pre-course meeting?
• How much home practice is expected each day?
• Are refresher or follow-up sessions offered after the eight weeks?
• If I want to taper my antidepressant, how will the course leaders coordinate with my prescriber?

What the evidence does not show

• It does not show that MBCT is better than staying on maintenance antidepressants.
• It does not show a benefit for people with only two previous episodes in the original trial.
• It does not show that general mindfulness apps or classes give the same protection as MBCT.
• It does not remove relapse risk; it lowers it on average.

How this practice approaches relapse prevention

The practice's ongoing care combines psychiatric evaluation and medication management with psychotherapy, including CBT and DBT, coaching, and nutrition and lifestyle psychiatry. Whether the team offers MBCT or another structured relapse-prevention program is a question to raise on the free discovery call. If you are on an antidepressant and thinking about the long-term plan, the practice's prescribers can review options with you; see medication management and the Patient Interest Form. More guides are collected in Choosing Psychiatric Care.

Frequently asked questions

Can I take MBCT if I am still on an antidepressant?

Yes. Many MBCT participants in research were taking antidepressants, and NICE describes combining continued medication with MBCT or group CBT as one option. Any change to medication should be planned with your prescriber.

Is MBCT available online?

Some MBCT courses are run by video. The PREVENT trial described here used in-person groups, so ask the course leader how the online version is structured and whether it follows the standard program.

How is MBCT different from meditation?

MBCT uses meditation practices, but it is a structured therapy program with a depression-specific curriculum, cognitive therapy elements and a written relapse-prevention plan.

What if I miss a session?

Most courses expect regular attendance because each week builds on the last. Ask in advance how missed sessions are handled and whether recordings or catch-up material are provided.

Does MBCT help anxiety?

MBCT was developed and mainly tested for preventing depressive relapse. Anxiety disorders have their own first-line treatments, so discuss the right fit with a clinician.

Should I stop my antidepressant after finishing MBCT?

Not on your own. Stopping can cause discontinuation symptoms and depression can return. If you want to come off medication, plan a gradual taper with your prescriber.

Sources

1. Prevention of relapse/recurrence in major depression by mindfulness-based cognitive therapy. Journal of Consulting and Clinical Psychology (Teasdale JD et al.), PubMed 10965637, 2000. pubmed.ncbi.nlm.nih.gov
2. Efficacy of Mindfulness-Based Cognitive Therapy in Prevention of Depressive Relapse: An Individual Patient Data Meta-analysis From Randomized Trials. JAMA Psychiatry (Kuyken W et al.), PubMed 27119968, 2016. pubmed.ncbi.nlm.nih.gov
3. Effectiveness and cost-effectiveness of mindfulness-based cognitive therapy compared with maintenance antidepressant treatment in the prevention of depressive relapse or recurrence (PREVENT): a randomised controlled trial. The Lancet (Kuyken W et al.), PubMed 25907157, 2015. kclpure.kcl.ac.uk
4. Depression in adults: treatment and management (NG222), Recommendations. National Institute for Health and Care Excellence (NICE), 2022. nice.org.uk

Educational information, not medical, tax or legal advice. Decisions about diagnosis, medication and treatment belong with a clinician who knows your history.